Chronos Wealth Management
ABBV icon

Chronos Wealth Management’s AbbVie ABBV Stock Holding History

Chronos Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$323K Hold
1,236
– – 0.14% 37
2026
Q2 		$311K Hold
1,236
– – 0.14% 37
2026
Q1 		$269K Sell
1,236
-8
-0.6% -$1.78K 0.13% 38
2025
Q4 		$284K Hold
1,244
– – 0.13% 37
2025
Q3 		$288K Hold
1,244
– – 0.14% 36
2025
Q2 		$231K Hold
1,244
– – 0.12% 38
2025
Q1 		$261K Hold
1,244
– – 0.14% 33
2024
Q4 		$221K Hold
1,244
– – 0.11% 42
2024
Q3 		$246K Buy
+1,244
New +$232K 0.13% 38

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Chronos Wealth Management's ABBV Position: Q3 2026 in Review

Chronos Wealth Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,236 shares worth $323K. The position accounts for 0.14% of the portfolio, ranked #37.

Chronos Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 2,951 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Chronos Wealth Management held 1,236 shares of AbbVie worth $323K as of Q3 2026.
  • Chronos Wealth Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.14% of Chronos Wealth Management's portfolio in Q3 2026, its #37 holding.
  • Chronos Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
  • 2,951 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Chronos Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.